We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$419M
AUM Growth
+$51.7M
Cap. Flow
+$5.75M
Cap. Flow %
1.37%
Top 10 Hldgs %
31.11%
Holding
110
New
12
Increased
24
Reduced
47
Closed
9

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.11M
2
CPRI icon
Capri Holdings
CPRI
+$5.87M
3
MCK icon
McKesson
MCK
+$3.46M
4
COR icon
Cencora
COR
+$3.16M
5
GGG icon
Graco
GGG
+$3.13M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$6.63M
2
EBAY icon
eBay
EBAY
+$5.21M
3
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
+$4.96M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$3.38M
5
TS icon
Tenaris
TS
+$3.29M

Sector Composition

Rank Sector Weight
1 Healthcare 28.9%
2 Financials 15.15%
3 Industrials 14.25%
4 Consumer Discretionary 10.89%
5 Technology 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WASH icon
76
Washington Trust Bancorp
WASH
$732M
$472K 0.11%
12,700
-1,723
-12% -$59.1K
XOM icon
77
ExxonMobil
XOM
$650B
$461K 0.11%
4,563
-300
-6% -$27.7K
ADP icon
78
Automatic Data Processing
ADP
$99.9B
$460K 0.11%
6,492
– –
IBM icon
79
IBM
IBM
$203B
$431K 0.1%
2,406
-104
-4% -$17.9K
SJM icon
80
J.M. Smucker
SJM
$12.6B
$414K 0.1%
4,000
– –
ATHN
81
DELISTED
Athenahealth, Inc.
ATHN
$403K 0.1%
+3,000
New +$385K
MDT icon
82
Medtronic
MDT
$107B
$395K 0.09%
+6,892
New +$391K
SJI
83
DELISTED
South Jersey Industries, Inc.
SJI
$391K 0.09%
14,000
-400
-3% -$11.4K
NBIX icon
84
Neurocrine Biosciences
NBIX
$17.6B
$386K 0.09%
41,350
-7,400
-15% -$72.2K
DHI icon
85
D.R. Horton
DHI
$40.7B
$374K 0.09%
16,800
-6,500
-28% -$126K
GE icon
86
GE Aerospace
GE
$365B
$325K 0.08%
2,420
+271
+13% +$34.1K
TMO icon
87
Thermo Fisher Scientific
TMO
$210B
$311K 0.07%
2,800
-350
-11% -$34.8K
BRK.B icon
88
Berkshire Hathaway Class B
BRK.B
$1.06T
$296K 0.07%
2,500
– –
AMX icon
89
America Movil
AMX
$78.5B
$283K 0.07%
12,110
-1,400
-10% -$30.5K
CVS icon
90
CVS Health
CVS
$137B
$272K 0.06%
3,806
– –
PETM
91
DELISTED
PETSMART INC
PETM
$265K 0.06%
3,650
-41,600
-92% -$3.04M
PNY
92
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$265K 0.06%
8,000
+500
+7% +$16.5K
IART icon
93
Integra LifeSciences
IART
$1.54B
$260K 0.06%
13,377
– –
MSFT icon
94
Microsoft
MSFT
$2.86T
$258K 0.06%
6,900
– –
JNJ icon
95
Johnson & Johnson
JNJ
$633B
$256K 0.06%
2,800
+45
+2% +$4.15K
UNP icon
96
Union Pacific
UNP
$183B
$248K 0.06%
2,964
– –
INTC icon
97
Intel
INTC
$473B
$237K 0.06%
9,141
– –
ECL icon
98
Ecolab
ECL
$75.5B
$234K 0.06%
2,250
-25
-1% -$2.6K
ORCL icon
99
Oracle
ORCL
$335B
$218K 0.05%
5,700
-700
-11% -$24.1K
ABT icon
100
Abbott
ABT
$180B
$217K 0.05%
5,677
-200
-3% -$7.37K
1 2 3
4
5

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q4 2013 Portfolio in Review

As of Q4 2013, De Burlo Group held 110 positions worth $419M, up 14% from $367M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

De Burlo Group's Q4 2013 filing shows 12 new, 24 increased, 47 reduced and 9 closed positions. Its largest new stake was Celgene Corp: 89,800 shares worth $7.59M. The largest sale was Alexion Pharmaceuticals, an estimated $6.63M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

  • De Burlo Group's largest Q4 2013 buy was Celgene Corp: 89,800 shares worth $7.59M.
  • De Burlo Group added most to McKesson in Q4 2013, an estimated $3.46M increase.
  • De Burlo Group's biggest Q4 2013 reduction was Alexion Pharmaceuticals, cutting an estimated $6.63M.
  • De Burlo Group fully exited eBay in Q4 2013, selling an estimated $5.21M.
  • De Burlo Group's ten largest holdings make up 31% of its $419M portfolio in Q4 2013.
  • De Burlo Group opened 12 new positions and closed 9 in Q4 2013.
  • De Burlo Group's portfolio value rose 14% quarter-over-quarter to $419M.

Based on De Burlo Group's 13F filing for Q4 2013, filed 7 Feb 2014.